{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:51:45Z","timestamp":1791085905631,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T00:00:00Z","timestamp":1327449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes have been observed among HIV-seropositive illicit drug users. As there is an urgent need to improve responses to antiretroviral therapy among this population, we undertook this study to evaluate the role of physician experience on rates of plasma HIV-1 RNA suppression following initiation of ART.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using data from a community-recruited cohort of HIV-positive illicit drug users, we used Cox proportional hazards regression to model the time to plasma viral HIV RNA &lt; 500 copies\/mL among antiretroviral-na\u00efve subjects initiating ART. Physician experience was defined as a continuous variable measured per 100 HIV-infected patients previously enrolled in the province-wide HIV treatment registry by that physician at the time a patient was enrolled.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between May 1996 and December 2008, 267 individuals initiated ART among whom 227 (85%) achieved a plasma HIV RNA &lt; 500 copies\/mL during the study period. In a multivariate analysis, greater physician experience was independently associated with higher rates of plasma HIV RNA suppression (adjusted hazard ratio [AHR] = 1.17, 95% confidence interval [CI]: 1.03-1.34) after adjustment for adherence to ART. Other factors associated with viral suppression included engagement in methadone maintenance therapy (AHR = 1.61, 95% CI: 1.23-2.09), \u2265 95% adherence to ART (AHR = 2.42, 95% CI: 1.80-3.26), baseline CD4 count (AHR = 0.89, 95% CI: 0.83-0.96) and baseline plasma HIV-1 RNA (AHR = 0.65, 95% CI: 0.53-0.81).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this setting of universal HIV\/AIDS care, illicit drug users with more experienced physicians exhibited faster rates of plasma viral load suppression. These findings argue for specialized services to help optimize HIV treatment outcomes among this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-22","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T19:16:19Z","timestamp":1327518979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study"],"prefix":"10.1186","volume":"12","author":[{"given":"Sassan","family":"Sangsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,25]]},"reference":[{"key":"1705_CR1","volume-title":"Joint united nations programme on HIV\/AIDS (UNAIDS). Geneva, Switzerland","author":"Joint United Nations Programme on HIV\/AIDS","year":"2011","unstructured":"Joint United Nations Programme on HIV\/AIDS: UNAIDS report on the global AIDS epidemic 2010. Joint united nations programme on HIV\/AIDS (UNAIDS). Geneva, Switzerland. 2011"},{"issue":"9651","key":"1705_CR2","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, et al: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008, 372 (9651): 1733-1745. 10.1016\/S0140-6736(08)61311-2.","journal-title":"Lancet"},{"issue":"3","key":"1705_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.2010.1004","volume":"304","author":"MA Thompson","year":"2010","unstructured":"Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Gunthard HF, Hammer SM, Hirsch MS, et al: Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010, 304 (3): 321-333. 10.1001\/jama.2010.1004.","journal-title":"JAMA"},{"issue":"Suppl 3","key":"1705_CR4","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1097\/00126334-200212153-00005","volume":"31","author":"N Press","year":"2002","unstructured":"Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS: Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S112-117.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"1705_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","volume":"17","author":"JH Arnsten","year":"2002","unstructured":"Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE: Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002, 17 (5): 377-381.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"1705_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1086\/424008","volume":"39","author":"AR Moss","year":"2004","unstructured":"Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR: Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004, 39 (8): 1190-1198. 10.1086\/424008.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1705_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1001\/archinte.165.6.618","volume":"165","author":"L Ding","year":"2005","unstructured":"Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD: Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med. 2005, 165 (6): 618-623. 10.1001\/archinte.165.6.618.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1705_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS: Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998, 280 (6): 547-549. 10.1001\/jama.280.6.547.","journal-title":"JAMA"},{"issue":"5","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jama.300.5.550","volume":"300","author":"E Wood","year":"2008","unstructured":"Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, Montaner JS: Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008, 300 (5): 550-554. 10.1001\/jama.300.5.550.","journal-title":"JAMA"},{"issue":"8","key":"1705_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1086\/507680","volume":"194","author":"R Gross","year":"2006","unstructured":"Gross R, Yip B, Lo Re V, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JS, Hogg RS: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006, 194 (8): 1108-1114. 10.1086\/507680.","journal-title":"J Infect Dis"},{"issue":"11","key":"1705_CR11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S: Simulation study of confounder-selection strategies. Am J Epidemiol. 1993, 138 (11): 923-936.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"1705_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/infdis\/jir032","volume":"203","author":"MJ Milloy","year":"2011","unstructured":"Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, Montaner J, Wood E: Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011, 203 (9): 1215-1221. 10.1093\/infdis\/jir032.","journal-title":"J Infect Dis"},{"issue":"11","key":"1705_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199603143341106","volume":"334","author":"MM Kitahata","year":"1996","unstructured":"Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH: Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996, 334 (11): 701-706. 10.1056\/NEJM199603143341106.","journal-title":"N Engl J Med"},{"issue":"5","key":"1705_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00002030-200303280-00009","volume":"17","author":"E Wood","year":"2003","unstructured":"Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS: Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS. 2003, 17 (5): 711-720. 10.1097\/00002030-200303280-00009.","journal-title":"AIDS"},{"issue":"6","key":"1705_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/09540120020014264","volume":"12","author":"N Escaffre","year":"2000","unstructured":"Escaffre N, Morin M, Bouhnik AD, Fuzibet JG, Gastaut JA, Obadia Y, Moatti JP: Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs. AIDS Care. 2000, 12 (6): 723-730. 10.1080\/09540120020014264.","journal-title":"AIDS Care"},{"issue":"1","key":"1705_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1497.2002.09004.x","volume":"17","author":"LG Miller","year":"2002","unstructured":"Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, Ma Y, Kaplan AH, Wenger NS: How well do clinicians estimate patients' adherence to combination antiretroviral therapy?. J Gen Intern Med. 2002, 17 (1): 1-11. 10.1046\/j.1525-1497.2002.09004.x.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","volume":"84","author":"A Palepu","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS: Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006, 84 (2): 188-194. 10.1016\/j.drugalcdep.2006.02.003.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-2007-986320","volume":"58","author":"U Engelbach","year":"2008","unstructured":"Engelbach U, Dannecker M, Kaufhold J, Lenz C, Grabhorn R: Adherence as a result of a \"particular relationship\". HIV-infected patients about their physician-patient relationship. Psychother Psychosom Med Psychol. 2008, 58 (6): e1-e14. 10.1055\/s-2007-986320.","journal-title":"Psychother Psychosom Med Psychol"},{"issue":"7","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1468-1293.2008.00582.x","volume":"9","author":"E Wood","year":"2008","unstructured":"Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS: Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med. 2008, 9 (7): 503-507. 10.1111\/j.1468-1293.2008.00582.x.","journal-title":"HIV Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:29:09Z","timestamp":1630520949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,25]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-22","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,25]]},"assertion":[{"value":"29 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}